National Health Investors, Inc. (NYSE:NHI) Short Interest Update

National Health Investors, Inc. (NYSE:NHI) saw a large decrease in short interest during the month of July. As of July 15th, there was short interest totaling 2,094,689 shares, a decrease of 44.0% from the June 30th total of 3,740,952 shares. Currently, 4.4% of the shares of the stock are sold short. Based on an average trading volume of 441,598 shares, the short-interest ratio is currently 4.7 days.

Analyst Ratings Changes

NHI has been the subject of a number of research analyst reports. Wells Fargo & Company lowered their price target on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a report on Monday, June 1st. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $94.00 price objective on shares of National Health Investors in a research report on Wednesday, April 22nd. BMO Capital Markets reduced their target price on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a report on Monday, June 15th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a research note on Thursday, June 25th. Finally, Truist Financial decreased their price target on National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a report on Friday, June 12th. Five research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, National Health Investors presently has an average rating of “Moderate Buy” and a consensus price target of $83.86.

Insider Buying and Selling

In related news, Director Robert A. Mccabe, Jr. purchased 890 shares of the company’s stock in a transaction dated Monday, June 15th. The stock was acquired at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the transaction, the director directly owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO D. Eric Mendelsohn bought 1,500 shares of the business’s stock in a transaction on Friday, June 5th. The stock was bought at an average cost of $68.84 per share, with a total value of $103,260.00. Following the completion of the purchase, the chief executive officer directly owned 133,316 shares in the company, valued at approximately $9,177,473.44. The trade was a 1.14% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Company insiders own 2.70% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of NHI. International Assets Investment Management LLC acquired a new stake in shares of National Health Investors during the fourth quarter worth $27,000. EverSource Wealth Advisors LLC increased its stake in National Health Investors by 244.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after buying an additional 288 shares during the period. Garton & Associates Financial Advisors LLC purchased a new position in National Health Investors during the 4th quarter worth $33,000. GAMMA Investing LLC raised its position in National Health Investors by 41.8% during the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 136 shares during the last quarter. Finally, Key Capital Management INC acquired a new stake in shares of National Health Investors in the 4th quarter worth $47,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Stock Performance

Shares of NHI traded up $0.74 during mid-day trading on Friday, hitting $76.81. 383,476 shares of the company’s stock were exchanged, compared to its average volume of 385,122. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83. National Health Investors has a fifty-two week low of $67.94 and a fifty-two week high of $91.38. The business’s 50 day moving average is $75.13 and its two-hundred day moving average is $79.74. The firm has a market capitalization of $3.72 billion, a P/E ratio of 24.78, a P/E/G ratio of 3.42 and a beta of 0.51.

National Health Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date of this dividend is Tuesday, June 30th. National Health Investors’s dividend payout ratio (DPR) is presently 118.71%.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.